行情

CDMO

CDMO

Avid Bioservices
NASDAQ

实时行情|Nasdaq Last Sale

4.340
-0.340
-7.27%
已收盘, 16:00 04/03 EDT
开盘
4.570
昨收
4.680
最高
4.620
最低
4.280
成交量
23.92万
成交额
--
52周最高
8.38
52周最低
3.020
市值
2.45亿
市盈率(TTM)
-24.0844
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CDMO价格均价为9.00,最高价位10.00,最低价为6.00。

EPS

CDMO 新闻

更多
  • 跟谁学:审计意见措辞与友商不同 因享受萨班斯法案豁免
  • 新浪财经 · 2小时前
  • 油价收复失地 投资者权衡价格战停战的可能性
  • 新浪财经 · 2小时前
  • 驻日美军基地宣布进入公共卫生紧急状态
  • 新浪财经 · 3小时前
  • 石油谈判代表为减产协议奔走 美国的态度成关键
  • 新浪财经 · 3小时前

所属板块

制药
-0.14%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

CDMO 简况

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides a variety of process development activities, including cell line development and optimization.
展开

微牛提供Avid Bioservices Inc(NASDAQ-CDMO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CDMO股票新闻,以帮助您做出投资决策。